JWH-206

From WikiMD's Wellness Encyclopedia


JWH-206 is a synthetic cannabinoid from the naphthoylindole family, which acts as a potent agonist of the cannabinoid receptors. It was first synthesized by John W. Huffman and his team at Clemson University as part of research into the structure-activity relationships of cannabinoids.

Chemical Structure and Properties[edit | edit source]

JWH-206 is chemically classified as a naphthoylindole, which is a subclass of synthetic cannabinoids. Its IUPAC name is (4-methoxynaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone. The compound has a molecular formula of C25H25NO2 and a molecular weight of 371.47 g/mol.

The structure of JWH-206 consists of a naphthalene ring system substituted with a methoxy group at the 4-position, linked to an indole moiety via a ketone bridge. The indole is further substituted with a pentyl chain at the nitrogen atom.

Pharmacology[edit | edit source]

JWH-206 acts as a full agonist at the CB1 and CB2 cannabinoid receptors, with a higher affinity for the CB1 receptor. This receptor interaction is responsible for its psychoactive effects, which mimic those of tetrahydrocannabinol (THC), the primary active component of cannabis.

Legal Status[edit | edit source]

The legal status of JWH-206 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is often included in legislation targeting synthetic cannabinoids and "designer drugs."

Synthesis[edit | edit source]

The synthesis of JWH-206 involves the condensation of 4-methoxynaphthoyl chloride with 1-pentylindole in the presence of a base. This reaction forms the characteristic ketone linkage between the naphthalene and indole rings.

Potential Risks and Effects[edit | edit source]

As with other synthetic cannabinoids, the use of JWH-206 can pose significant health risks. These may include tachycardia, hypertension, hallucinations, and psychosis. The variability in potency and purity of synthetic cannabinoid products further increases the risk of adverse effects.

Research and Applications[edit | edit source]

JWH-206, like other synthetic cannabinoids, has been used in scientific research to study the endocannabinoid system and the effects of cannabinoid receptor activation. However, its use is limited due to its legal status and potential for abuse.

Also see[edit | edit source]




WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD